Drug Prices
The Centers for Medicare & Medicaid Services today updated the Parts B and D drug spending dashboards with 2016 information.
The Senate Health, Education, Labor and Pensions Committee today held the second in a series of hearings examining the 340B drug savings program.
The Department of Health and Human Services, May 14, issued a policy statement and request for information (RFI) on ways to lower drug prices and reduce out-of-pocket costs for consumers.
Health and Human Services Secretary Alex Azar today provided additional information on steps the agency will take to implement the president’s blueprint to lower prescription drug costs.
Another week, another drug industry-funded consultant attempting to divert attention away from the high and rising costs of prescription drugs by attacking the 340B drug pricing program.
President Trump today unveiled his administration’s blueprint to lower prescription drug prices, which also solicits input on potential actions the Department of Health and Human Services may take to improve competition and negotiation and lower costs.
Contact: Marie Johnson, (202) 626-2351
Colin Milligan, (202) 638-5491
The Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies today held a hearing on the Department of Health and Human Services’ funding request for fiscal year 2019.
Reducing regulations and expanding care models that ensure coordination and reward performance are two ways to address health care prices, AHA General Counsel Melinda Hatton said today during a Kaiser Family Foundation panel discussion focused on the issue.
Rep. Peter Roskam (R-IL), chairman of the Health Subcommittee on Ways and Means, today stressed the need for Congress to reduce certain regulations on providers that “have no relationship to patient health.”